gimli

FABTECH stock AI analysis

FABTECH Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

FABTECH TECHNOLOGIES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available FABTECH price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive FABTECH stock page

Price

₹151.40

1W return

-4.34%

1M return

-2.74%

3M return

-3.84%

6M return

-10.76%

1Y return

n/a

Market cap

₹672.99 cr

17.54

1.60

ROE

+12.94%

ROCE

+6.69%

RSI

39.94

Turnover

₹1.20 cr

Why it can matter in screens

Momentum: FABTECH is below 50DMA, below 200DMA; RSI is 39.94.
Returns: 1D -1.50%, 1W -4.34%, 1M -2.74%, 3M -3.84%, 1Y n/a.
Trend levels: 52W high ₹255.41, 52W low ₹133.90, off high -40.72%.
Liquidity: latest turnover is ₹1.20 cr; volume vs 20D is +0.31%.
Valuation/profitability: PE 17.54, PB 1.60, ROE +12.94%, ROCE +6.69%.
Growth: 3Y sales CAGR +28.45%, 3Y profit CAGR +20.85%.

Quick Answers

What is the latest FABTECH stock price?

The latest stored price for FABTECH is Rs 151.40 as of 2026-07-20.

Is FABTECH above its 50DMA and 200DMA?

FABTECH is below 50DMA, below 200DMA. The latest 50DMA is 155.41 and the latest 200DMA is n/a.

What are FABTECH PE, ROE and ROCE?

FABTECH has PE 17.54, ROE +12.94%, and ROCE +6.69% in Gimli's latest available snapshot.

How has FABTECH performed recently?

FABTECH has returned -2.74% over 1 month, -3.84% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	158.52 cr	32.06 cr	22.06 cr	5.75
2025-12-31	62.76 cr	-4.50 cr	-5.68 cr	-1.56
2025-09-30	124.28 cr	33.25 cr	28.11 cr	8.68
2025-06-30	68.96 cr	-5.27 cr	-6.13 cr	-1.89
2025-03-31	134.86 cr	21.65 cr	15.09 cr	3.39
2024-12-31	104.32 cr	24.62 cr	20.46 cr	4.60

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	410.77 cr	57.73 cr	38.36 cr	10.00
2025-03-31	326.67 cr	65.14 cr	46.45 cr	10.45
2024-03-31	226.14 cr	39.75 cr	27.22 cr	8.13
2023-03-31	193.80 cr	32.38 cr	21.73 cr	5.49
2022-03-31	259.54 cr	33.45 cr	22.63 cr	81.23

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	653.70 cr	86.88 cr	69.63 cr	419.77 cr
2025-03-31	426.56 cr	8.67 cr	83.83 cr	173.11 cr
2024-03-31	269.24 cr	26.84 cr	12.71 cr	131.88 cr
2023-03-31	213.86 cr	6.34 cr	35.45 cr	88.96 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	0.48 cr	-4.23 cr	n/a
2025-03-31	-36.14 cr	-60.93 cr	n/a
2024-03-31	60.43 cr	59.21 cr	n/a
2023-03-31	-13.89 cr	-14.21 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+68.94%	+0.02%	+2.45%	+0.00%	+28.58%	+0.00%
2026-03-31	+68.94%	+0.08%	+2.15%	+0.00%	+28.83%	+0.00%
2025-12-31	+68.94%	+0.03%	+1.99%	+0.00%	+29.04%	+0.00%
2025-10-06	+68.94%	+1.91%	+11.63%	+0.00%	+17.52%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	469,405.90 cr	40.823336	+14.71%	+15.52%
DIVISLAB	DIVI S LABORATORIES LTD	194,269.92 cr	75.650281	+16.19%	+8.71%
TORNTPHARM	TORRENT PHARMACEUTICALS L	169,405.46 cr	78.319677	+17.18%	+42.14%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,040.28 cr	65.380043	+21.03%	+21.93%
CIPLA	CIPLA LTD	116,452.52 cr	30.005339	+11.79%	-2.75%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,616.29 cr	23.056854	+17.93%	+17.85%
LUPIN	LUPIN LIMITED	113,320.96 cr	21.221472	+26.83%	+28.27%
MAXHEALTH	MAX HEALTHCARE INS LTD	107,290.40 cr	74.382732	+14.33%	-9.32%

Try these prompts

Analyze FABTECH TECHNOLOGIES with valuation, momentum and industry peers
Compare FABTECH with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-20. Not investment advice.